These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1521897)

  • 21. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis.
    Rousseau Y; Carreno MP; Poignet JL; Kazatchkine MD; Haeffner-Cavaillon N
    Biomaterials; 1999 Oct; 20(20):1959-67. PubMed ID: 10514074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers.
    Gabutti L; Taminelli-Beltraminelli L; Marone C
    Eur J Clin Pharmacol; 1997; 53(2):123-6. PubMed ID: 9403283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatibility study on cuprophane and polysulphone dialysers.
    Taraba I; Polner K; Makó J
    Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
    [No Abstract]   [Full Text] [Related]  

  • 26. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress.
    Kosch M; Levers A; Fobker M; Barenbrock M; Schaefer RM; Rahn KH; Hausberg M
    Nephrol Dial Transplant; 2003 Jul; 18(7):1370-5. PubMed ID: 12808175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis.
    Schaefer RM; Herfs N; Ormanns W; Hörl WH; Heidland A
    Clin Nephrol; 1988 Jun; 29(6):307-11. PubMed ID: 3396234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils.
    Padrines M; Schneider-Pozzer M; Bieth JG
    Am Rev Respir Dis; 1989 Mar; 139(3):783-90. PubMed ID: 2784294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
    Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
    Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Glorieux G; Waterloos MA; De Smet R; Lesaffer G; Lameire N
    Am J Kidney Dis; 2000 Dec; 36(6):1140-6. PubMed ID: 11096038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cuprophan, hemophan and polysulfone membranes on the oxidative metabolism, degranulation reaction, enzyme release and pulmonary sequestration of granulocytes.
    Kolb G; Fischer W; Schoenemann H; Bathke K; Höffken H; Müller T; Lange H; Joseph K; Havemann K
    Contrib Nephrol; 1989; 74():10-21. PubMed ID: 2562018
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes.
    Hörl WH; Steinhauer HB; Schollmeyer P
    Kidney Int; 1985 Nov; 28(5):791-6. PubMed ID: 3878906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of modern microscopic techniques for examining dialysis membrane properties].
    Kowal A; Nowak S; Sułowicz W; Pietrzyk JA; Krawentek L; Drozdz M; Nowogrodzka-Zagórska M; Bal W
    Przegl Lek; 2000; 57(12):702-6. PubMed ID: 11398590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte sequestration in dialysers: a comparative elution study of three different membranes.
    Grooteman MP; Nubé MJ; van Houte AJ; Schoorl M; van Limbeek J
    Nephrol Dial Transplant; 1995 Oct; 10(10):1859-64. PubMed ID: 8592594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.